| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 04/20/2010 | US7700755 cytotoxins; host cells; vaccines; histology |
| 04/20/2010 | US7700749 Nucleic acid and corresponding protein entitled 205P1B5 useful in treatment and detection of cancer |
| 04/20/2010 | US7700742 Antibodies to insulin-like growth factor I receptor |
| 04/20/2010 | US7700715 Kit for use in the diagnosis and treatment of cancer |
| 04/20/2010 | US7700657 Vitamin D analogs |
| 04/20/2010 | US7700605 2-cyano-pyrimidines and-triazines as cysteine protease inhibitors |
| 04/20/2010 | US7700586 Arylsulfonamide derivatives for use as ccr3 antagonists in the treatment of inflammatory and immunological disorders |
| 04/20/2010 | US7700584 antitumor agents; viricides |
| 04/20/2010 | US7700570 Oligonucleotide mediated specific cytokine induction and prophylaxis and treatment of viral infection in a mammal |
| 04/20/2010 | US7700569 Single- or double-stranded stabilized DNA contains nonmethylated octameric CG motif of the sequence AACGTTAT (nucleotides 9-16 of SEQ ID NO: 9); phosphorothioate oligonucleotides; nuclease inhibitors; immunostimulants; nontoxic; anticarcinogenic agents; intratumoral administration; nervous systems |
| 04/20/2010 | US7700560 Compounds comprising two human GlxI inhibitors covalently linked via a diacid where each of the inhibitors may be the same or different and is an S-substituted glutathione or a prodrug thereof having a gamma-glutamyl amino group; length >50 Angstroms; antitumor, -carcinogenic, -proliferative agents |
| 04/20/2010 | US7700558 Methods for treating diabetes using fibroblast growth factor-like polypeptides |
| 04/20/2010 | US7700557 for treating diseases relating to angiogenesis; fusion protein possesses ribosome inactivating activity and ability to bind to cellular vascular endothelial growth factor (VEGF) receptors |
| 04/20/2010 | US7700554 Compositions for modulating blood-brain barrier transport |
| 04/20/2010 | US7700341 Nucleic acid molecules encoding transmembrane serine proteases, the encoded proteins and methods based thereon |
| 04/20/2010 | US7700315 Comprises nucleotide sequences coding polypeptide with serine protease activity for use in identifying modulator and treaments for blood coagulation and cell proliferative disorders |
| 04/20/2010 | US7700314 Method for producing polyol-IFN-β conjugate |
| 04/20/2010 | US7700297 Artery- and vein-specific proteins and uses therefor |
| 04/20/2010 | US7700274 Compositions and methods in cancer associated with altered expression of KCNJ9 |
| 04/20/2010 | US7700271 Method of diagnosis and treatment and agents useful for same |
| 04/20/2010 | US7700114 original codons are exchanged by codons which lead to an enhanced translation in a mammalian cell, contain a deletion resulting in the production of a truncated non-functional protein; capable of enhancing the immunogenicity |
| 04/20/2010 | US7700104 Attenuated Salmonella SP12 mutants as antigen carriers |
| 04/20/2010 | US7700092 Pneumovirus NS proteins antagonize the interferon IFN response |
| 04/20/2010 | US7700087 Compounds and methods to inhibit or augment an inflammatory response |
| 04/20/2010 | CA2565411C Compounds and methods for inhibiting mitotic progression |
| 04/20/2010 | CA2561950C 6,6-bicyclic ring substituted heterobicyclic protein kinase inhibitors |
| 04/20/2010 | CA2515366C Compositions and methods to modulate immune and inflammatory responses |
| 04/20/2010 | CA2448356C N-phenylpyrrole guanidine derivatives as melanocortin receptor ligands |
| 04/20/2010 | CA2432178C Sustained release pharmaceutical dosage forms with minimized ph dependent dissolution profiles |
| 04/20/2010 | CA2419880C 2-pyridinyl-6,7,8,9-tetrahydropyrimido[1,2-a] pyrimidin-4-one and 7-pyridinyl-2,3-dihydroimidazo[1,2-a] pyrimidin-5(1h)one derivatives |
| 04/20/2010 | CA2418744C Novel aminocyclohexane derivatives |
| 04/20/2010 | CA2400172C Nanocapsule encapsulation system and method |
| 04/20/2010 | CA2393159C Methods of treating tumors |
| 04/20/2010 | CA2362331C Epoxide hydrolase complexes and methods therewith |
| 04/20/2010 | CA2361587C Methods and compositions to enhance white blood cell count |
| 04/20/2010 | CA2358925C Compositions and methods for use in targeting vascular destruction |
| 04/20/2010 | CA2348741C Nitrosasted and nitrosylated nonsteroidal antiinflammatory compounds, comositions and methods of use |
| 04/20/2010 | CA2306442C Human ribonuclease a with reduced ribonuclease inhibitor affinity |
| 04/20/2010 | CA2219876C Stable variant hk2 polypeptide |
| 04/20/2010 | CA2180872C Composition containing nucleic acids, preparation and uses |
| 04/15/2010 | WO2010042933A2 Inhibition and treatment of prostate cancer metastasis |
| 04/15/2010 | WO2010042925A2 Compositions and methods for treating alcohol use disorders, pain and other diseases |
| 04/15/2010 | WO2010042919A2 Method of making a vaccine |
| 04/15/2010 | WO2010042867A2 Activators of human pyruvate kinase |
| 04/15/2010 | WO2010042758A2 Oxazole-pyridazine-oxazole alpha-helix mimetic |
| 04/15/2010 | WO2010042699A1 Imidazopyridazinecarbonitriles useful as kinase inhibitors |
| 04/15/2010 | WO2010042685A2 Inhibitors of the atb(0,+) transporter and uses thereof |
| 04/15/2010 | WO2010042684A1 Pyrrolotriazine kinase inhibitors |
| 04/15/2010 | WO2010042644A2 Methods for inducing a sustained immune response againts a b-cell idiotype using autologous anti-idiotypic vaccines |
| 04/15/2010 | WO2010042638A2 Hpma - docetaxel or gemcitabine conjugates and uses therefore |
| 04/15/2010 | WO2010042636A2 Telomerase inhibitors and methods of use thereof |
| 04/15/2010 | WO2010042600A2 Photo-activatable therapeutic agents and methods of using |
| 04/15/2010 | WO2010042500A2 Heat shock protein 90 inhibitors, methods of preparing same, and methods for their use |
| 04/15/2010 | WO2010042489A2 Aminoquinoline derived heat shock protein 90 inhibitors, methods of preparing same, and methods for their use |
| 04/15/2010 | WO2010042445A1 Carbazole compounds and therapeutic uses of the compounds |
| 04/15/2010 | WO2010042225A2 Chemical modulators of pro-apoptotic bax and bcl-2 polypeptides |
| 04/15/2010 | WO2010042163A2 Quinoline compounds as inhibitors of angiogenesis, human methionine aminopeptidase, and sirt1, and methods of treating disorders |
| 04/15/2010 | WO2010041748A1 Fluorene compound and use thereof for medical purposes |
| 04/15/2010 | WO2010041617A1 Fusion protein composed of matrix metalloproteinase-2 inhibitor peptide derived from amyloid-β precursor protein and tissue inhibitor of metalloproteinase-2 |
| 04/15/2010 | WO2010041401A1 Protein phosphatase inhibitor |
| 04/15/2010 | WO2010041140A2 Treatment of proliferative disorders with a death receptor agonist |
| 04/15/2010 | WO2010041060A1 Targeted binding agents directed to heparanase and uses thereof 463 |
| 04/15/2010 | WO2010041054A1 Pyridine and pyrimidine based compounds as wnt signaling pathway inhibitors for the treatment of cancer |
| 04/15/2010 | WO2010040885A1 Dual cellular model of cancer |
| 04/15/2010 | WO2010040766A1 Neutralizing antibodies and fragments thereof directed against platelet factor-4 variant 1 (pf4v1) |
| 04/15/2010 | WO2010040750A1 3, 3', 4, 4' -tetrahydroxy-2, 2' -bipyridine-n, n' -dioxides for the treatment of renal cell carcinoma |
| 04/15/2010 | WO2010040562A1 A polymer-free hydrogel |
| 04/15/2010 | WO2010040527A1 Novel compounds which modulate kinase activity |
| 04/15/2010 | WO2010040305A1 Pharmaceutical being used for treating cancer and fibrosis disease and the composition and uses thereof |
| 04/15/2010 | WO2010040277A1 Cadherin-17 as diagnostic marker and therapeutic target for liver cancer |
| 04/15/2010 | WO2010040252A1 Epothilone glycoside compounds, compositions containing epothilone glycoside compounds as active components and uses thereof |
| 04/15/2010 | WO2010040212A1 Processes for the preparation of erlotinib hydrochloride |
| 04/15/2010 | WO2010040204A1 Detection of granulosa-cell tumors |
| 04/15/2010 | WO2010022249A3 Macrocyclic compounds for inhibition of tumor necrosis factor alpha |
| 04/15/2010 | WO2010017035A3 Inhibitors of iap |
| 04/15/2010 | WO2010014784A9 Combination of anti-ctla4 antibody with diverse therapeutic regimens for the synergistic treatment of proliferative diseases |
| 04/15/2010 | WO2010012965A3 Combination of a tlr3 ligand and a chemotherapy agent which acts on the intrinsic “apoptosis” pathway in the treatment of cancer |
| 04/15/2010 | WO2010006343A3 Glycopeptide constructs and uses thereof |
| 04/15/2010 | WO2010006169A3 2-methylene-19, 26-dinor-(20s, 22e, 25r)-vitamin d analogs |
| 04/15/2010 | WO2010006135A3 2-methylene-(17z)-17(20)-dehydro-19,21-dinor-vitamin d analogs |
| 04/15/2010 | WO2010006086A3 Kinase inhibitors and methods of use |
| 04/15/2010 | WO2010005558A3 Pi3k isoform selective inhibitors |
| 04/15/2010 | WO2010003668A3 Treatment of solid tumors with tissue inhibitors of metalloproteinases (timps) |
| 04/15/2010 | WO2010002911A3 Methods and materials for monitoring myeloma using quantitative mass spetrometry |
| 04/15/2010 | WO2009146218A3 Compounds including an anti-inflammatory pharmacore and methods of use |
| 04/15/2010 | WO2009143018A3 Pyrrolo [2, 3-d] pyrimidines as fm and kit kinase modulators |
| 04/15/2010 | WO2009134396A3 Use of corticotropin-releasing factor for the treatment of cancer |
| 04/15/2010 | WO2009123934A3 Branched multifunctional nanoparticle conjugates and their use |
| 04/15/2010 | WO2009120697A4 Method and compositions for treatment of cancer |
| 04/15/2010 | WO2009118660A4 Adam-15 antibodies and immunogenic peptides |
| 04/15/2010 | WO2009112021A3 Pharmaceutical composition for the diagnosis or treatment of a plasmocytoma |
| 04/15/2010 | WO2009071753A8 4-phenyl-1,3-thiazole and 4-phenyl-1,3-oxazole derivatives as cannabinoid receptor ligands |
| 04/15/2010 | WO2008124085A3 Methods of using combinations of mek and jak-2 inhibitors |
| 04/15/2010 | US20100095390 Aldolases, Nucleic Acids Encoding Them and Methods for Making and Using Them |
| 04/15/2010 | US20100094408 Drug-Delivery Endovascular Stent and Method for Treating Restenosis |
| 04/15/2010 | US20100094003 Process for preparing inhibitors of nucleoside phosphorylases and nucleosidases |
| 04/15/2010 | US20100093862 Potentiation of cellular immunity using histone deacetylase (hdac) inhibitors. |
| 04/15/2010 | US20100093842 Laulimalide Analogs and Uses Thereof |
| 04/15/2010 | US20100093840 Human Sef isoforms and methods of using same for cancer diagnosis and gene therapy |
| 04/15/2010 | US20100093839 hypoxia-inducible factor-1 alpha (HIP-1 alpha); nucleosides, Locked Nucleic Acids; treating kidney cancer, melanoma, glioblastoma and prostate cancer, and pre-eclampsia |